Raptor Pharmaceutical Corp Accounts Receivable, after Allowance for Credit Loss
Raptor Pharmaceutical Corp had Accounts Receivable, after Allowance for Credit Loss of $15.73 million as of 2016-06-30, per its 10-Q filed 2016-08-04.
Discontinued › Balance Sheet › Assets
us-gaap:AccountsReceivableNet · last filed 2016-08-04
- 2016-06-30: Accounts Receivable, after Allowance for Credit Loss $15.73M.
- 2016-03-31: Accounts Receivable, after Allowance for Credit Loss $17.86M.
- 2015-12-31: Accounts Receivable, after Allowance for Credit Loss $13.27M.
- 2015-09-30: Accounts Receivable, after Allowance for Credit Loss $15.49M.
| Period end | Accounts Receivable, after Allowance for Credit Loss |
|---|---|
| 2016-06-30 | $15.73M 10-Q · filed 2016-08-04 |
| 2016-03-31 | $17.86M 10-Q · filed 2016-05-05 |
| 2015-12-31 | $13.27M 10-Q · filed 2016-08-04 |
| 2015-09-30 | $15.49M 10-Q · filed 2015-11-05 |
| 2015-06-30 | $13.17M 10-Q · filed 2015-08-06 |
| 2015-03-31 | $10.85M 10-Q · filed 2015-05-07 |
| 2014-12-31 | $7.46M 10-K · filed 2016-02-26 |
| 2014-09-30 | $10.48M 10-Q · filed 2014-11-06 |
| 2014-06-30 | $5.78M 10-Q · filed 2014-08-07 |
| 2014-03-31 | $7.08M 10-Q · filed 2014-05-09 |
| 2013-12-31 | $6.18M 10-K · filed 2015-03-02 |
| 2013-09-30 | $5.52M 10-Q/A · filed 2014-05-12 |
| 2013-06-30 | $26.00K 10-Q/A · filed 2014-05-12 |
| 2012-12-31 | $0.00 10-Q/A · filed 2014-05-12 |